Dave N.T. Aryee

1.3k total citations
31 papers, 965 citations indexed

About

Dave N.T. Aryee is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Dave N.T. Aryee has authored 31 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Dave N.T. Aryee's work include Sarcoma Diagnosis and Treatment (13 papers), RNA modifications and cancer (9 papers) and RNA Research and Splicing (5 papers). Dave N.T. Aryee is often cited by papers focused on Sarcoma Diagnosis and Treatment (13 papers), RNA modifications and cancer (9 papers) and RNA Research and Splicing (5 papers). Dave N.T. Aryee collaborates with scholars based in Austria, United States and Germany. Dave N.T. Aryee's co-authors include Heinrich Kovar, Jozef Ban, A. Zoubek, Raphaela Schwentner, Idriss M. Bennani-Baı̈ti, Maximilian Kauer, Christine Siligan, Laura Spahn, Gunhild Jug and Erica A. Golemis and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Dave N.T. Aryee

30 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dave N.T. Aryee Austria 17 614 483 250 153 124 31 965
Didier Surdez France 18 653 1.1× 516 1.1× 263 1.1× 220 1.4× 172 1.4× 33 1.2k
Eric D. Young United States 18 376 0.6× 408 0.8× 276 1.1× 184 1.2× 99 0.8× 33 943
Karine Laud-Duval France 6 360 0.6× 371 0.8× 165 0.7× 174 1.1× 79 0.6× 7 651
Takahiro Gotoh Japan 17 710 1.2× 360 0.7× 313 1.3× 308 2.0× 118 1.0× 27 1.2k
David Van Mater United States 14 540 0.9× 152 0.3× 174 0.7× 143 0.9× 61 0.5× 24 869
Domenico Trombetta Italy 12 358 0.6× 209 0.4× 266 1.1× 247 1.6× 83 0.7× 36 731
Hilary Blair United States 12 429 0.7× 249 0.5× 169 0.7× 319 2.1× 114 0.9× 17 1.2k
Joanna Selfe United Kingdom 15 510 0.8× 266 0.6× 200 0.8× 175 1.1× 98 0.8× 26 819
Juan‐Han Yu China 17 409 0.7× 200 0.4× 226 0.9× 124 0.8× 88 0.7× 62 775
Christina Fleet United States 9 638 1.0× 246 0.5× 441 1.8× 101 0.7× 41 0.3× 11 1.0k

Countries citing papers authored by Dave N.T. Aryee

Since Specialization
Citations

This map shows the geographic impact of Dave N.T. Aryee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dave N.T. Aryee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dave N.T. Aryee more than expected).

Fields of papers citing papers by Dave N.T. Aryee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dave N.T. Aryee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dave N.T. Aryee. The network helps show where Dave N.T. Aryee may publish in the future.

Co-authorship network of co-authors of Dave N.T. Aryee

This figure shows the co-authorship network connecting the top 25 collaborators of Dave N.T. Aryee. A scholar is included among the top collaborators of Dave N.T. Aryee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dave N.T. Aryee. Dave N.T. Aryee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Radic-Sarikas, Branka, Maximilian Kauer, Sandra Högler, et al.. (2021). YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells. Oncogenesis. 10(1). 2–2. 36 indexed citations
2.
3.
Schwentner, Raphaela, Dave N.T. Aryee, Edgard M. Mejia, et al.. (2017). EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells. Oncotarget. 8(15). 24679–24693. 21 indexed citations
4.
Ban, Jozef, Dave N.T. Aryee, Wietske van der Ent, et al.. (2014). Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma. Cancer Research. 74(22). 6578–6588. 57 indexed citations
5.
Bennani-Baı̈ti, Idriss M., Dave N.T. Aryee, Jozef Ban, et al.. (2011). Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma. The Journal of Pathology. 225(3). 353–363. 26 indexed citations
6.
Aryee, Dave N.T., Maximilian Kauer, Raphaela Schwentner, et al.. (2010). Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells In vitro. Cancer Research. 70(10). 4015–4023. 57 indexed citations
7.
Bennani-Baı̈ti, Idriss M., Aaron Cooper, Elizabeth R. Lawlor, et al.. (2010). Intercohort Gene Expression Co-Analysis Reveals Chemokine Receptors as Prognostic Indicators in Ewing's Sarcoma. Clinical Cancer Research. 16(14). 3769–3778. 56 indexed citations
8.
Aryee, Dave N.T., Maximilian Kauer, Robert L. Walker, et al.. (2010). Abstract 444: Hypoxia modulates EWS-FLI1 transcriptional signature and enhances invasiveness and anchorage-independent growth of Ewing's sarcoma cells in-vitro. Cancer Research. 70(8_Supplement). 444–444. 3 indexed citations
9.
Aryee, Dave N.T., et al.. (2009). Abstract #247: HIF-1\#945; mediates hypoxia modulation of EWS-FLI1 expression in Ewing\#8217;s sarcoma family tumors. Cancer Research. 69. 247–247. 1 indexed citations
10.
Ban, Jozef, Idriss M. Bennani-Baı̈ti, Max Kauer, et al.. (2008). EWS-FLI1 Suppresses NOTCH-Activated p53 in Ewing's Sarcoma. Cancer Research. 68(17). 7100–7109. 79 indexed citations
11.
Aryee, Dave N.T., Aykut Üren, Stephan N. Wagner, et al.. (2006). Single-chain Antibodies to the EWS NH2 Terminus Structurally Discriminate between Intact and Chimeric EWS in Ewing's Sarcoma and Interfere with the Transcriptional Activity of EWS In vivo. Cancer Research. 66(20). 9862–9869. 9 indexed citations
12.
Siligan, Christine, Jozef Ban, Laura Spahn, et al.. (2005). EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin. Oncogene. 24(15). 2512–2524. 66 indexed citations
13.
Spahn, Laura, et al.. (2003). Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein. Oncogene. 22(44). 6819–6829. 43 indexed citations
14.
Aryee, Dave N.T., Inge M. Ambros, Peter F. Ambros, et al.. (2002). Frequent Low Level Expression in Ewing Sarcoma Family Tumors and Widespread Absence of the Metastasis Suppressor KAI1/CD82 in Neuroblastoma. Pediatric Research. 52(2). 279–285. 6 indexed citations
15.
Kovar, Heinrich, Frits J. Fallaux, Ingrid Pribill, et al.. (2000). Adenovirus E1A does not induce the Ewing tumor-associated gene fusion EWS-FLI1.. PubMed. 60(6). 1557–60. 8 indexed citations
16.
Aryee, Dave N.T., et al.. (2000). Variability in Gene Expression Patterns of Ewing Tumor Cell Lines Differing in EWS-FLI1 Fusion Type. Laboratory Investigation. 80(12). 1833–1844. 29 indexed citations
17.
Kovar, Heinrich, Dave N.T. Aryee, & A. Zoubek. (1999). The Ewing family of tumors and the search for the Achilles’ heel. Current Opinion in Oncology. 11(4). 275–275. 46 indexed citations
18.
Aryee, Dave N.T., et al.. (1998). Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II. Oncogene. 17(5). 603–610. 121 indexed citations
19.
Kovar, Heinrich, Gunhild Jug, Dave N.T. Aryee, et al.. (1997). Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Oncogene. 15(18). 2225–2232. 107 indexed citations
20.
Aryee, Dave N.T., Thomas Ströbel, M. Véron, et al.. (1995). High nm23‐h1/ndpk‐a expression in ewing tumors: Paradoxical immunohistochemical reactivity and lack of prognostic significance. International Journal of Cancer. 64(2). 104–111. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Didier Surdez Breakdown of academic impact, for papers by Eric D. Young Breakdown of academic impact, for papers by Karine Laud-Duval Breakdown of academic impact, for papers by Takahiro Gotoh Breakdown of academic impact, for papers by David Van Mater Breakdown of academic impact, for papers by Domenico Trombetta Breakdown of academic impact, for papers by Hilary Blair Breakdown of academic impact, for papers by Joanna Selfe Breakdown of academic impact, for papers by Juan‐Han Yu Breakdown of academic impact, for papers by Christina Fleet
Rankless by CCL
2026